cyc 202 has been researched along with bromodeoxyuridine in 9 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 13,164 | 71 | 1,816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Henfling, ME; Meijer, L; Nieland, L; Ramaekers, FC; Schutte, B; van Engeland, M | 1 |
| Bang, YJ; Hong, SH; Jong, HS; Kim, NK; Kim, SG; Kim, SJ; Kim, SN | 1 |
| Bravo, R; Bruna, A; Caelles, C; Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jorda, EG; Pallàs, M; Pubill, D; Verdaguer, E | 1 |
| Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jordá, EG; Pallàs, M; Pubill, D; Verdaguer, E | 1 |
| Cowan, RG; Harman, RM; Quirk, SM | 1 |
| Blow, JJ; Ge, XQ | 1 |
| Hirotsune, S; Kumamoto, K; Sato, M; Takitoh, T; Toba, S; Wang, CC; Wynshaw-Boris, A | 1 |
| Rolfes, S; Schierwater, B; von der Chevallerie, K | 1 |
9 other study(ies) available for cyc 202 and bromodeoxyuridine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Kinetin; Lung Neoplasms; Mitosis; Neuroblastoma; Purines; Roscovitine; S Phase; Tumor Cells, Cultured | 1997 |
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Topics: Annexin A5; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Kinetin; Microtubule-Associated Proteins; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Purines; Retinoblastoma Protein; RNA, Messenger; Roscovitine; Stomach Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |
Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Anthracenes; Anti-Bacterial Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Count; Cell Survival; Cells, Cultured; Cerebellum; Chromatin; Colchicine; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Flavonoids; Flow Cytometry; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Kainic Acid; MAP Kinase Kinase 4; Microtubules; Minocycline; Mitogen-Activated Protein Kinase Kinases; Neurons; Neuroprotective Agents; Piperidines; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Time Factors; Tubulin | 2003 |
Antiapoptotic effects of roscovitine in cerebellar granule cells deprived of serum and potassium: a cell cycle-related mechanism.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Caspase 3; Caspase Inhibitors; Caspases; Cell Cycle; Cerebellum; Culture Media, Serum-Free; Enzyme Activation; Immunohistochemistry; Potassium; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2004 |
The susceptibility of granulosa cells to apoptosis is influenced by oestradiol and the cell cycle.
Topics: Animals; Apoptosis; Biomarkers; Bromodeoxyuridine; Cattle; Cell Proliferation; Cells, Cultured; Cyclins; Estradiol; Estrogen Antagonists; Fas Ligand Protein; Female; Flow Cytometry; Fulvestrant; G1 Phase; Granulosa Cells; Hydroxyurea; Immunohistochemistry; Interphase; Ki-67 Antigen; Membrane Glycoproteins; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Purines; Random Allocation; Roscovitine; S Phase; Tumor Necrosis Factors | 2006 |
Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories.
Topics: Aphidicolin; Ataxia Telangiectasia Mutated Proteins; Bromodeoxyuridine; Caffeine; Carbocyanines; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Deoxyuracil Nucleotides; DNA; DNA Damage; DNA Replication; Fibroblasts; Gamma Rays; Humans; Hydroxyurea; Models, Biological; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Purines; Replication Origin; RNA, Small Interfering; Roscovitine | 2010 |
Activation of Aurora-A is essential for neuronal migration via modulation of microtubule organization.
Topics: Amiodarone; Analysis of Variance; Animals; Animals, Newborn; Aurora Kinase A; Aurora Kinases; Bromodeoxyuridine; Calcium-Binding Proteins; Carrier Proteins; Cell Cycle Proteins; Cell Movement; Cells, Cultured; Cerebellum; Cyclin-Dependent Kinase 5; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Male; Mice; Mice, Transgenic; Microscopy, Confocal; Microtubule-Associated Proteins; Microtubules; Mutation; Neurons; Phosphorylation; Piperazines; Pregnancy; Protein Serine-Threonine Kinases; Purines; RNA, Small Interfering; Roscovitine; Sex Factors; Signal Transduction | 2012 |
Inhibitors of the p53-Mdm2 interaction increase programmed cell death and produce abnormal phenotypes in the placozoon Trichoplax adhaerens (F.E. Schulze).
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Proliferation; Humans; Imidazoles; In Situ Nick-End Labeling; Phenotype; Piperazines; Placozoa; Protein Binding; Proto-Oncogene Proteins c-mdm2; Purines; Roscovitine; Time Factors; Tumor Suppressor Protein p53 | 2014 |